Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared on X:
“Now discussing the transformative impact of cellular therapies in hematologic malignancies and solid tumors at the National ICE-T Congress in Orlando.
Exciting advances, insightful discussions, and a shared vision for the future of cancer care.”
Other articles about National ICE-T Congress on OncoDaily.
